AstraZeneca | Results Presentation Deck | 39 slides

AstraZeneca · 2022-02
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
front_matter
Open slide detailBeat · Attention
06
The slide uses a three-column layout to categorize performance metrics and operational highlights.summarize
Open slide detailBeat · NeedLoop · Logic Chain
07
The slide presents two side-by-side tables comparing FY 2021 and Q4 2021 performance metrics.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
08
The slide uses a combination of a product portfolio table and two pie charts to illustrate business strategy.summarize
Open slide detailBeat · NeedLoop · Logic Chain
09
The slide uses a four-column layout to categorize strategic growth drivers.summarize
Open slide detailBeat · NeedLoop · Logic Chain
10
The slide uses a table format to categorize pipeline progress by regulatory status and geography.summarize
Open slide detailBeat · NeedLoop · Logic Chain
11
transition
Open slide detailBeat · Satisfaction
12
Includes footnotes regarding CER (constant exchange rates) and expense definitions.analyze_data
Open slide detailBeat · Satisfaction
13
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.analyze_data
Open slide detailBeat · Satisfaction
14
Includes historical performance data from 2018-2021 and 2022 guidance ranges.analyze_data
Open slide detailBeat · Satisfaction
15
The bridge chart includes a significant acquisition-related debt increase.analyze_data
Open slide detailBeat · Satisfaction
16
transition
Open slide detailBeat · Satisfaction
17
The slide uses stacked bar charts to visualize revenue growth by region (US, Europe, ERoW, EM) for two key products.analyze_data
Open slide detailBeat · Satisfaction
18
Includes a stacked bar chart for product sales, a list of regional growth drivers, and a stacked bar chart for collaboration revenue.analyze_data
Open slide detailBeat · Satisfaction
19
Includes product imagery and detailed footnotes for medical abbreviations.analyze_data
Open slide detailBeat · Satisfaction
20
The slide uses a three-column layout to summarize data from three different medical congresses.summarize
Open slide detailBeat · Satisfaction
21
Slide number 4 in the deck.transition
Open slide detailBeat · Satisfaction
22
Includes a stacked bar chart for Farxiga revenue and a line chart for Lokelma market share.analyze_data
Open slide detailBeat · Satisfaction
23
Slide provides a breakdown of revenue, market share, and launch status for three specific pharmaceutical products.analyze_data
Open slide detailBeat · Satisfaction
24
The slide uses a combination of big numbers and a table to illustrate the addressable patient population.quantify_opportunity
Open slide detailBeat · Satisfaction
25
The chart shows a stacked bar breakdown of revenue by region (China vs Ex-China) and COVID-19 vaccine sales over 9 quarters.analyze_data
Open slide detailBeat · Satisfaction
26
The slide uses a three-column layout to detail clinical and commercial status for three drugs.summarize
Open slide detailBeat · ActionLoop · Cost Of Inaction
27
The slide uses a stylized human silhouette with digital/molecular overlays.transition
Open slide detailBeat · ActionLoop · Cost Of Inaction
28
Slide 28 of a presentation, likely from AstraZeneca's financial reporting.analyze_data
Open slide detailBeat · ActionLoop · Cost Of Inaction
29
The slide uses a combination of patient population visualization (icons) and a mechanism-of-action (MOA) mapping against disease severity (NYHA scale).present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
30
The slide uses a Gantt-style chart to visualize drug development phases.present_solution
Open slide detailBeat · ActionLoop · Cost Of Inaction
31
closing_ask
Open slide detailBeat · Action
32
The slide uses a matrix structure (timeline vs. activity type) to organize upcoming milestones.plan_implementation
33
The slide uses a four-pillar structure to summarize the company's strategic outlook.summarize
34
The slide features headshots and titles for 8 executives.other
36
The chart visualizes emission reduction paths for various companies, while the table ranks them by temperature alignment.compare_peers
37
The slide is split into two distinct tables: Oncology (left) and BioPharmaceuticals: CVRM (right).analyze_data
38
analyze_data